Systems Biology Methodologies for the Understanding of Common Oncogenetic Mechanisms in Childhood Leukemic and Rhabdomyosarcoma Cells

Systems Biology Methodologies for the Understanding of Common Oncogenetic Mechanisms in Childhood Leukemic and Rhabdomyosarcoma Cells

George I. Lambrou, Maria Adamaki, Eleftheria Koultouki, Maria Moschovi
ISBN13: 9781613501207|ISBN10: 161350120X|EISBN13: 9781613501214
DOI: 10.4018/978-1-61350-120-7.ch007
Cite Chapter Cite Chapter

MLA

Lambrou, George I., et al. "Systems Biology Methodologies for the Understanding of Common Oncogenetic Mechanisms in Childhood Leukemic and Rhabdomyosarcoma Cells." Quality Assurance in Healthcare Service Delivery, Nursing and Personalized Medicine: Technologies and Processes, edited by Athina Lazakidou and Andriani Daskalaki , IGI Global, 2012, pp. 111-168. https://doi.org/10.4018/978-1-61350-120-7.ch007

APA

Lambrou, G. I., Adamaki, M., Koultouki, E., & Moschovi, M. (2012). Systems Biology Methodologies for the Understanding of Common Oncogenetic Mechanisms in Childhood Leukemic and Rhabdomyosarcoma Cells. In A. Lazakidou & A. Daskalaki (Eds.), Quality Assurance in Healthcare Service Delivery, Nursing and Personalized Medicine: Technologies and Processes (pp. 111-168). IGI Global. https://doi.org/10.4018/978-1-61350-120-7.ch007

Chicago

Lambrou, George I., et al. "Systems Biology Methodologies for the Understanding of Common Oncogenetic Mechanisms in Childhood Leukemic and Rhabdomyosarcoma Cells." In Quality Assurance in Healthcare Service Delivery, Nursing and Personalized Medicine: Technologies and Processes, edited by Athina Lazakidou and Andriani Daskalaki , 111-168. Hershey, PA: IGI Global, 2012. https://doi.org/10.4018/978-1-61350-120-7.ch007

Export Reference

Mendeley
Favorite

Abstract

Therefore, let us imagine a best case scenario where oncogenesis is understood, at least in part, and drug design, effectiveness, and side effects could be resolved by simply modeling the system. This would dramatically reduce drug costs, with positive consequences not only for treatment, but also on the social level. Drugs would become much more affordable, hence curing and improving the lives of more people. This hypothetical, best-case scenario should point scientists to move towards the direction of attempting to make scientific endeavors for the social benefit. Systems biology is a discipline that does indeed move towards that direction. Of course, as most things in life, the use of systems biology could be used in a dual manner, that is, for social benefit or profit.

Request Access

You do not own this content. Please login to recommend this title to your institution's librarian or purchase it from the IGI Global bookstore.